UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma

Archives of pathology & laboratory medicine (1976), 2014-06, Vol.138 (6), p.828-832

2014

Volltextzugriff (PDF)

Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins

Clinical cancer research, 2014-11, Vol.20 (22), p.5697-5707

2014

Volltextzugriff (PDF)

Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil

Revista da Sociedade Brasileira de Medicina Tropical, 2017-01, Vol.50 (1), p.67-74

2017

Volltextzugriff (PDF)

Are opossums a relevant factor associated with asymptomatic Leishmania infection in the outskirts of the largest Brazilian cities?

The Brazilian journal of infectious diseases, 2016-03, Vol.20 (2), p.119-126

2016

Volltextzugriff (PDF)

Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients

Clinica chimica acta, 2014-02, Vol.429, p.168-174

2014

Volltextzugriff (PDF)

Blue/NIR-emitting Phosphor Based on Sr2CeO4: Tm3+, Yb3+ Obtained by Combustion Synthesis

Medžiagotyra, 2023-08, Vol.29 (3), p.285-290

2023

Volltextzugriff (PDF)

Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study

Journal of neuro-oncology, 2013-12, Vol.115 (3), p.429-435

2013

Volltextzugriff (PDF)

A Prospective Study of Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness: Should We Use It or Not?

Journal of pain and symptom management, 2013-11, Vol.46 (5), p.e1-e3

2013

Volltextzugriff (PDF)

Clinical Management of Small-Cell Carcinoma of the Urinary Tract: A 10-Year Single-Center's Experience

Clinical genitourinary cancer, 2013-06, Vol.11 (2), p.168-174

2013

Volltextzugriff (PDF)

Lyme disease in the state of Tocantins, Brazil: report of the first cases

The Brazilian journal of infectious diseases, 2012-11, Vol.16 (6), p.586-589

2012

Volltextzugriff (PDF)

Genus-specific kinetoplast-DNA PCR and parasite culture for the diagnosis of localised cutaneous leishmaniasis: applications for clinical trials under field conditions in Brazil

Memórias do Instituto Oswaldo Cruz, 2009-11, Vol.104 (7), p.992-997

2009

Volltextzugriff (PDF)

Safety and Efficacy of Maintenance Therapy With a Nonspecific Cytochrome P17 Inhibitor (CYP17i) After Response/Stabilization to Docetaxel in Metastatic Castration-Resistant Prostate Cancer

Clinical genitourinary cancer, 2013-06, Vol.11 (2), p.78-84

2013

Volltextzugriff (PDF)

Efficacy and safety of erdafitinib in adults with NSCLC and prespecified fibroblast growth factor receptor alterations in the phase 2 open-label, single-arm RAGNAR trial

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8515-8515

2024

Volltextzugriff (PDF)

Clinical investigations for SUS, the Brazilian public health system

São Paulo medical journal, 2012-01, Vol.130 (3), p.179-186

2012

Volltextzugriff (PDF)

Tumour-agnostic efficacy and safety of erdafitinib in patients with advanced solid tumours with prespecified FGFR alterations: RAGNAR phase 2 study primary analysis

The lancet oncology, 2023-08, Vol.24 (8), p.925-935

2023

Volltextzugriff (PDF)

Tumor agnostic efficacy and safety of erdafitinib (erda) in patients (pts) with advanced solid tumors with prespecified FGFR alterations ( FGFRalt ): RAGNAR primary analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3121-3121

2023

Volltextzugriff (PDF)

Editorial

Revista Omnia, 2023-03, Vol.6 (1), p.7

Carranza, Omar

2023

Volltextzugriff (PDF)

Editorial

Revista Omnia, 2022-09, Vol.5 (2), p.7-8

Carranza, Omar

2022

Volltextzugriff (PDF)

Editorial

Revista Omnia, 2021-09, Vol.4 (4), p.7-8

Carranza, Omar

2021

Volltextzugriff (PDF)

EGFR-activating mutations and treatment with tyrosine-kinase inhibitors (TKI) to revert poor-prognosis (PP) associated with liver metastases (LM) in stage IV non-small cell lung cancer (NSCLC) patients (pts)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e19106-e19106

2013

Volltextzugriff (PDF)

Adrenalectomy for low-tumor-burden metastatic lung cancer: Results of a single institution experience

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e19114-e19114

2013

Volltextzugriff (PDF)

Safety and efficacy of maintenance therapy (MT) with a nonspecific cytochrome-P 17 inhibitor (CYP17i) after response/stabilization to docetaxel in metastatic castratation-resistant prostate cancer (mCRPC) patients

Journal of clinical oncology, 2012-02, Vol.30 (5_suppl), p.145-145

2012

Volltextzugriff (PDF)

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(119)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma

Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)

Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins

Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil

Are opossums a relevant factor associated with asymptomatic Leishmania infection in the outskirts of the largest Brazilian cities?

Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients

Blue/NIR-emitting Phosphor Based on Sr2CeO4: Tm3+, Yb3+ Obtained by Combustion Synthesis

Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study

A Prospective Study of Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness: Should We Use It or Not?

Clinical Management of Small-Cell Carcinoma of the Urinary Tract: A 10-Year Single-Center's Experience

Lyme disease in the state of Tocantins, Brazil: report of the first cases

Genus-specific kinetoplast-DNA PCR and parasite culture for the diagnosis of localised cutaneous leishmaniasis: applications for clinical trials under field conditions in Brazil

Safety and Efficacy of Maintenance Therapy With a Nonspecific Cytochrome P17 Inhibitor (CYP17i) After Response/Stabilization to Docetaxel in Metastatic Castration-Resistant Prostate Cancer

Efficacy and safety of erdafitinib in adults with NSCLC and prespecified fibroblast growth factor receptor alterations in the phase 2 open-label, single-arm RAGNAR trial

Clinical investigations for SUS, the Brazilian public health system

Tumour-agnostic efficacy and safety of erdafitinib in patients with advanced solid tumours with prespecified FGFR alterations: RAGNAR phase 2 study primary analysis

Tumor agnostic efficacy and safety of erdafitinib (erda) in patients (pts) with advanced solid tumors with prespecified FGFR alterations ( FGFRalt ): RAGNAR primary analysis

Editorial

Editorial

Editorial

Efficacy and Safety of Nivolumab in Previously Treated Patients With Non–Small-cell Lung Cancer: Real World Experience in Argentina

Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk of Relapse

EGFR-activating mutations and treatment with tyrosine-kinase inhibitors (TKI) to revert poor-prognosis (PP) associated with liver metastases (LM) in stage IV non-small cell lung cancer (NSCLC) patients (pts)

Adrenalectomy for low-tumor-burden metastatic lung cancer: Results of a single institution experience

Safety and efficacy of maintenance therapy (MT) with a nonspecific cytochrome-P 17 inhibitor (CYP17i) after response/stabilization to docetaxel in metastatic castratation-resistant prostate cancer (mCRPC) patients

Suchergebnisse filtern